Zeiss invests in MicroOptx

Carl Zeiss Meditec last week announced that it is a new shareholder of MicroOptx.

Minneapolis-based MicroOptx develops minimally invasive glaucoma surgery devices. The technology is designed to provide effective reduction of intraocular pressure with one surgical procedure.

Zeiss’s investment will support the surgical treatments for glaucoma and complement its equipment and consumables in ophthalmic surgery.

“The investment in MicroOptx will give Zeiss an early position in this new technology designed to increase MIGS adoption for treating glaucoma,” James Mazzo, president of ophthalmic devices at Zeiss, said in a press release.

Engineering Better Devices at DeviceTalks Minnesota DeviceTalks Minnesota's engineering track is designed to provide attendees with with actionable lessons in a peer-to-peer format on topics such as: Human factors engineering Patient-centric device development R&D trends Manufacturing and scalability Navigating the product development process from start to finish "How We Built This" panels with top medical device groups Join industry leaders and medical device professionals at the most awaited medtech conference of the year, DeviceTalks Minnesota. Use code DT15 to save 15%! REGISTER NOW